The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-Analysis

The authors systematically reviewed the association between provider case volume and mortality in 101 publications involving greater than 1 million patients with esophageal, gastric, hepatic, pancreatic, colon, or rectal cancer, of whom more than 70,000 died. The majority of studies… Read moreThe Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-Analysis

Advances in Understanding and Management of Myeloproliferative Neoplasms

According to the 2008 World Health Organization classification system for hematologic malignancies, the myeloproliferative neoplasms (MPN) include chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, primary myelofibrosis, mastocytosis, chronic eosinophilic leukemia-not otherwise specified, chronic neutrophilic leukemia, and “MPN, unclassifiable.” All of… Read moreAdvances in Understanding and Management of Myeloproliferative Neoplasms

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

The primary goals of oncologic therapy are the compassionate care of cancer patients, eradication of disease, and palliation of symptoms. Advances in various targeted therapies such as highly conformal and image-guided radiotherapy techniques, sentinel lymph node dissection, and molecularly targeted… Read moreLymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Pharmacogenetics and pharmacogenomics of anticancer agents

Large interindividual variation is observed in both the response and toxicity associated with anticancer therapy. The etiology of this variation is multifactorial, but is due in part to host genetic variations. Pharmacogenetic and pharmacogenomic studies have successfully identified genetic variants… Read morePharmacogenetics and pharmacogenomics of anticancer agents

Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening

Each year, the American Cancer Society (ACS) publishes a report summarizing its recommendations for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In 2008, the ACS, the American Gastroenterological Association, the… Read moreCancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening